Selective screening for inborn errors of metabolism using tandem mass spectrometry in West Kazakhstan children: study

Gulmira Zharmakhanova1, Victoria Kononets1, Saule Balmagambetova2

  • 1Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.

Frontiers in Genetics
|January 29, 2024
PubMed

Insights

This study screens for inborn errors of metabolism in children in western Kazakhstan, establishing reference values for metabolites and assessing disease prevalence to improve newborn screening programs.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Limited data exists on the prevalence of inborn errors of metabolism (IEMs) in Kazakhstan.
  • Hereditary metabolic diseases pose a significant health burden, necessitating accurate diagnostic tools.

Purpose of the Study:

  • To conduct selective screening for IEMs in children (1 day to 18 years) in western Kazakhstan using LC-MS/MS.
  • To establish reference values for amino acids, acylcarnitines, and succinylacetone in healthy Kazakh children.
  • To determine the prevalence, age distribution, and age of onset of detected IEMs.

Main Methods:

  • Selective screening of 1,500 at-risk children using LC-MS/MS.
  • Establishing reference values using blood samples from 750 healthy children.
  • Diagnosis confirmed by clinical signs, metabolite levels, organic acids, and genetic testing.

Main Results:

  • Assessment of 37 IEM frequencies in high-risk pediatric population.
  • Establishing crucial reference ranges for key metabolites in children.
  • Data will inform national selective and expanded newborn screening programs.

Conclusions:

  • This research will provide the first comprehensive data on IEM prevalence in western Kazakhstan.
  • Findings will enable the development and enhancement of national newborn screening initiatives.
  • Improved diagnostic capabilities for hereditary metabolic diseases in the region.